$UNH Nearing its highest Daily RSI ever in history... Still down 40% from ATH's. I still like this name regardless.
Buy or sell guide
Should I Buy UNH Stock Right Now?
A fast read on Wall Street conviction, live analyst commentary on X, and current valuation context for UnitedHealth Group Incorporated.
Updated 2026-05-06
Wall Street currently rates UNH buy with a 12-month price target of $385 (+5.9% upside). See live commentary from high-reach stock analysts on X, plus the bull case, key risks, and the latest earnings execution.
Wall Street
Buy52 analystsConsensus target
$385 target (+5.9%)Current price $363.87Analyst sentiment
Bullish from 4 recent analyst posts4 bull · 0 bear · 0 neutralEarnings context
EPS beat 9.9%Reported Tue Apr 21Wall Street verdict
Should I Buy UNH Stock? Here's What Analysts Think
52 analysts currently cover UNH. Below is their consensus rating, price target range, and implied upside.
According to 52 analysts, UnitedHealth Group Incorporated (UNH) is rated Buy with a consensus 12-month price target of $385 — representing 6% upside from today's price of $364. The bull case target is $444, the bear case is $327.
UNHBuy
From 52 analyst ratings- Current price
- $363.87
- Consensus Target
- $385 (+5.9% upside)
- Forward P/E
- 19.9x
- Coverage
- 52 analyst ratings
High target$444
Low target$327
At $363.87, the consensus setup implies +5.9% versus the 12-month target.
- 42 of 52 analysts lean Buy or Strong Buy, while 6 stay on Hold and 4 lean bearish.
- UNH trades at roughly 19.9x forward earnings, so the bull case still depends on growth staying strong.
- Analysts span a wide range from $327 to $444, so conviction matters as much as the consensus target.
Below, compare that institutional answer with the live analyst commentary on X for UNH right now.
13 of 13 analysts raised targetsJP Morgan $420TD Cowen $337Morgan Stanley $395+5 more
May 2026Live commentary on X· Last 14 days · 4 takes
What Analysts Are Saying About UnitedHealth Group Incorporated Right Now
Real posts from high-reach stock analysts mentioning UNH, shown exactly as written. Sorted by engagement — most discussed first.
Recent high-reach analyst commentary leans bullish — the loudest voices on X are giving the tape the benefit of the doubt.
Bullish·
4 Bullish0 Neutral0 Bearish
$UNH #UNH Starting to move up above the supply area that price has been moving through the last 4 weeks. https://t.co/imcbt14H11
$UNH $UNHG The 2x etf of UNH is up almost 100% from the lows just a few weeks ago. 😱 The holy grail $400 mark not to far off again. I think we get there later this year.
$UNH Solid add on today. $400 on deck!?! https://t.co/I0LrakaGIh
Posts sourced from high-follower stock analysts on X. Bullish/bearish signals are auto-classified; verify on the original post before acting.
Should you buy UNH?
Is UNH a Buy, Hold, or Sell Right Now?
A structured look at the bull case, the risks, and the most recent earnings execution for UNH before you decide whether to buy, hold, or sell.
Current setup
UNH beat estimates last quarter. Below are the key reasons analysts remain constructive and the risks that could change that view.
Bull Case
What keeps the long thesis intact
- Improved Medical Care RatioQ1 2026 MCR improved to 83.9%, down from 84.8% in Q1 2025, indicating better management of medical costs.
- Raised EPS GuidanceUnitedHealth raised its full-year 2026 EPS guidance to over $18.25, reflecting management's confidence.
- Strong Q1 2026 EarningsQ1 2026 EPS was $7.23, exceeding expectations by 10%, with revenue at $111.7 billion.
- Attractive ValuationThe stock trades at a forward P/E ratio of 13x-19x, the cheapest in over a decade, attracting value investors.
- Operational Discipline FocusShift towards operational discipline and margin improvement signals long-term stability.
- Positive Analyst SentimentConsensus rating of 'Moderate Buy' with a majority recommending 'Buy' or 'Strong Buy'.
Wall Street rates UNH buy, giving the bull case institutional backing from 52 analysts.
Watch Out For
What can break the setup quickly
- DOJ InvestigationsOngoing investigations by the DOJ into Medicare Advantage billing practices pose significant risks.
- Membership Losses ExpectedUNH anticipates losing over 3 million members in 2026, leading to the first revenue decline in a decade.
- Rising Margin PressureAdjusted medical care ratio rose to 88.9% in FY2025, indicating rising utilization trends and funding cuts.
- Leadership TurbulenceSignificant leadership changes, including a CEO murder and resignation, could impact stability.
- Value Trap RisksDespite low valuation, ongoing investigations and operational challenges may limit upside potential.
- Negative Analyst RatingsSome analysts have issued 'Sell' ratings due to concerns about valuation and growth.
Watch whether new negative commentary on UNH points to these structural risks or is simply reacting to short-term price moves.
UNH Earnings Reaction — What the Last Quarter Showed
Last Quarter
- EPS
- $7.23 vs $6.58 est.Beat 9.9%
- Revenue
- $111.7B vs $109.4B est.Beat 2.1%
Full UNH Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy UNH Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See UNH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs UNH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare with Peers
Compare business quality, growth, and profitability against top sector peers.
Start ComparisonUNH — Frequently Asked Questions
Quick answers to the most common questions about buying UNH stock.
Should I buy UNH stock right now?
Verdict
UNH appears fairly valued near today's $363.87 — the consensus rating is "Buy" with a $385 target (+5.9%). The council of high-follower analysts on X is currently signalling bullish. This is informational only — verify the data and consider your own risk tolerance before deciding.
Is now a good time to buy UNH?
Timing
Timing depends on your horizon, but the data signals are: consensus rating "Buy" with +5.9% upside to the $385 target. In the past 30 days, 13 of 13 covering analysts raised their price targets — a bullish signal.
What is the price target for UNH stock?
Price Target
UNH's consensus 12-month price target is $385, set by 52 Wall Street analysts. The bull case high is $444 and the bear case low is $327. From the current price of $363.87, this implies +5.9% upside.
Is UNH overvalued or undervalued?
Valuation
UNH appears fairly valued — the $385 consensus target is roughly in line with today's $363.87 (+5.9%). It trades at a forward P/E of 19.9x. Targets range from $327 (bear) to $444 (bull), reflecting different assumptions about growth and margins.
Should I buy UNH before earnings?
Earnings
UNH reports next quarter. Earnings-week moves are volatile — historically, analyst targets revise upward after a beat and downward after a miss. The current consensus is "Buy" with a $385 target. Consider position sizing rather than going all-in pre-print.
What are analysts saying about UNH stock?
Coverage
Of 52 analysts covering UnitedHealth Group Incorporated (UNH): 0 Strong Buy, 42 Buy, 6 Hold, 4 Sell, 0 Strong Sell — a "Buy" consensus. The 12-month price target is $385 (range $327–$444). Bullish analysts outnumber bearish by more than 2-to-1.
What are the risks of buying UNH stock?
Risks
4 of the 52 analysts covering UNH rate it Sell or Strong Sell. Common concerns include valuation stretch, slowing growth, and sector-specific headwinds — see the Bull vs. Risk cards above for the specific theses on UnitedHealth Group Incorporated.
This page is for informational purposes only and does not constitute financial advice. Always conduct your own research before investing.